Cerebras Boosts 2026 Forecast Amid OpenAI and Hyperscaler Deals
Cerebras expects $940–960M in 2026 revenue as it expands capacity to support a $20B OpenAI contract and new hyperscaler agreements.
Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
Cerebras expects $940–960M in 2026 revenue as it expands capacity to support a $20B OpenAI contract and new hyperscaler agreements.
Cisco shares rose after beating estimates with record revenue and raising its AI hyperscaler target to $9B while lifting full-year guidance.
Special committees of independent directors are reviewing a possible SpaceX-Tesla combination valued around $3.5 trillion.
CD&R and GTCR have dropped early-stage take-private talks for Global Payments after weeks of discussions, citing deal complexity and tight financing markets.
US DOJ is probing Supermicro over ties to Alice Huang, the alleged Chinese spy at the center of the Jensen Huang affair that forced his Nvidia resignation.
MSCI will remove Strategy from major indexes on Dec 1 after classifying it as a non-operating firm, risking passive fund outflows and its bitcoin accumulation model.